scholarly journals Return of Thoroughbred Racing Horses to the Races after Treating Slab Fractures of the Third Carpal Bone with PRP and Stem Cells

2021 ◽  
Vol 49 ◽  
Author(s):  
Janaina Godinho Louzada ◽  
Paulo De Tarso Landgraf Botteon ◽  
Luciana Rodrigues de Almeida Figueiredo ◽  
Hélio Cunha de Menezes Neto ◽  
Adiléa Cavalcanti Marques ◽  
...  

 Background: Despite the fact that slab fracture of the third carpal bone is an event of great worldwide relevance in racehorses, the third carpal fracture doesn’t have data on treatments and return to racing in Brazil. The search for efficient treatments and which provide recovery providing horses return to racing is an objective of sports equine medicine. Regenerative therapies like Platelet Rich Plasma (PRP) and Stem Cells (MSc) have demonstrated a great potential in the treatment of several injuries. For the treatment of three Thoroughbred racing horses at Brazilian Jockey Club, with sagittal plane slab fractures of the third carpal bone, we used the association of PRP and Stem Cells for reduction of the rest and good return to conditions athletics of these horses.Cases: Three Thoroughbred racing horses, males, 4 and 5 years old, showed slab fracture third carpal bone in different moments of their activity at Brazilian Jockey Club. Usually, the treatment for this type of fracture is the arthroscopic repair and the conservative management. We performed after initial radiographic evaluation dorsoproximal-dorsodistal oblique (DPr-DDiO) “skyline”, intra-articular applications of PRP and MSCs. The treatments were performed according to the radiographic follow-up of the lesion evolution. No other treatment was performed concomitantly with cell therapy in the 3 treated patients. Three treatments were performed in the first patient and 2 in the second and third patients. Before each treatment for all patients, we performed radiography dorsoproximal-dorsodistal oblique (DPr-DDiO) ‘skyline’ of the carpus. After this step, the animal was sedated with 10% xylazine hydrochloride at a dose of 0.5 mg/kg intravenously. Antisepsis of the carpus was performed and applied with radiographic monitoring of the needle positioning, first the PRP in the volume of 2 mL and in sequence, 20 million cells MSCs suspended in autologous plasma from the cell bank of the Cellen veterinary stem cell laboratory, totalizing 4 mL. The 3 horses returned to their training routines and continued to be monitored by clinical examinations and radiography, there were no post-treatment complications and all ran again in the median time of 253 days after the first application of PRP and stem cells. Everyone won the first race after treatment.Discussion: The 3 patients suffered the fractures after running at the Brazilian Jockey Club. All fractures were simple- no comminuted slab fractures of the third carpal. In our study, we chose to carry out the treatments with PRP and MSCs by intra-articular application. The regenerative medicine occupies a prominent place in recovery from injuries and the association of PRP and MSCs have played an important role in the treatment of athlete horses in tendons, bones and joint injuries and our work, the treatment was effective, without complications, helped to reduce local inflammation, perceptually reducing the pain observed before the application and the animals started running again with a quality equivalent to that observed before the occurrence of injuries. This way, our results demonstrated that the association PRP and MSCs was effective in recovering the 3 patients, all of them ran after injury. The median time for racing was 253 days and the horses won their first races after fractures occurred. These results encourage the use of the association of PRP and MSCs also for no comminuted sagittal plane slab fractures of the third carpal in Thoroughbred Racing horses.

2020 ◽  
Vol 52 (5) ◽  
pp. 692-698
Author(s):  
Rose Tallon ◽  
Henry O’Neill ◽  
Bruce Bladon

1989 ◽  
Vol 02 (03) ◽  
pp. 125-128
Author(s):  
E. M. Gaughan ◽  
N. G. Duchar

SummaryImplant associated fractures have not been reported in horses. Two horses were evaluated for fractures in the fore limbs, occurring subsequent to previous fracture repair. Previously, the horses had sustained fractures of unusual configurations which were repaired using internal fixation. Following repair and healing of the fractures, secondary fractures occurred in the same bone, but in a different (more common) configuration. The first horse was evaluated ten months following lag screw fixation of a longitudinal fracture of the proximal phalanx in a frontal plane. This horse presented with a more typical comminuted fracture in the sagittal plane with the screws from the first fixation lying in the fracture line. This fracture was successfully treated with a cast. The second horse was examined eightteen months after repair of a medial sagittal slab fracture of the third carpal bone. The horse presented with a more typical dorsal slab fracture of the third carpal bone with the previously placed lag screw lying in the fracture line. The screw was removed and a lag screw was placed perpendicular to the new fracture plane through the dorsal surface of the third carpal bone to repair the fracture.


2010 ◽  
Vol 36 (5) ◽  
pp. 441-446 ◽  
Author(s):  
B. J. HOPPER ◽  
C. STEEL ◽  
J. L. RICHARDSON ◽  
G. R. ALEXANDER ◽  
I. D. ROBERTSON

2019 ◽  
Vol 42 (3) ◽  
pp. 740-754
Author(s):  
Heba Saad Eldien ◽  
Nashwa Mostafa ◽  
Ola Abd ElTawab ◽  
Hussein Hassan ◽  
Tarek Abd Elhamid ◽  
...  

RSC Advances ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 5128-5138
Author(s):  
Ji Li ◽  
Ketao Wang ◽  
Xiaowei Bai ◽  
Qi Wang ◽  
Ningyu Lv ◽  
...  

Porous Ti6AI4V scaffolds incorporated with MSC and PRP are more effective in enhancing the bone regeneration.


2021 ◽  
Vol 22 (4) ◽  
pp. 1538 ◽  
Author(s):  
Pietro Gentile ◽  
Simone Garcovich

The number of clinical trials evaluating adipose-derived mesenchymal stem cells (AD-MSCs), platelet-rich plasma (PRP), and biomaterials efficacy in regenerative plastic surgery has exponentially increased during the last ten years. AD-MSCs are easily accessible from various fat depots and show intrinsic plasticity in giving rise to cell types involved in wound healing and angiogenesis. AD-MSCs have been used in the treatment of soft tissue defects and chronic wounds, employed in conjunction with a fat grafting technique or with dermal substitute scaffolds and platelet-rich plasma. In this systematic review, an overview of the current knowledge on this topic has been provided, based on existing studies and the authors’ experience. A multistep search of the PubMed, MEDLINE, Embase, PreMEDLINE, Ebase, CINAHL, PsycINFO, Clinicaltrials.gov, Scopus database, and Cochrane databases has been performed to identify papers on AD-MSCs, PRP, and biomaterials used in soft tissue defects and chronic wounds. Of the 2136 articles initially identified, 422 articles focusing on regenerative strategies in wound healing were selected and, consequently, only 278 articles apparently related to AD-MSC, PRP, and biomaterials were initially assessed for eligibility. Of these, 85 articles were excluded as pre-clinical, experimental, and in vitro studies. For the above-mentioned reasons, 193 articles were selected; of this amount, 121 letters, expert opinions, commentary, and editorials were removed. The remaining 72 articles, strictly regarding the use of AD-MSCs, PRP, and biomaterials in chronic skin wounds and soft tissue defects, were analyzed. The studies included had to match predetermined criteria according to the patients, intervention, comparator, outcomes, and study design (PICOS) approach. The information analyzed highlights the safety and efficacy of AD-MSCs, PRP, and biomaterials on soft tissue defects and chronic wounds, without major side effects.


Sign in / Sign up

Export Citation Format

Share Document